SFDA CEO Congratulates Saudi Leadership on Eid al-Fitr
Summary
The CEO of the Saudi Food and Drug Authority (SFDA) extended Eid al-Fitr greetings to the Saudi leadership and people. The announcement also highlighted the SFDA's role in ensuring the safety of food, medicine, and medical devices during the Umrah season.
What changed
The Saudi Food and Drug Authority (SFDA) issued a notice on March 10, 2026, where its CEO, Dr. Hisham S. Aljadhey, conveyed Eid al-Fitr greetings to the Saudi leadership and public. The statement also acknowledged the SFDA's contributions to public health and safety during the Umrah season, emphasizing its role in regulating food, medicine, and medical devices.
This notice is primarily informational and celebratory, marking a religious holiday. It does not introduce new regulatory requirements or deadlines for compliance. Compliance officers should note the SFDA's stated commitment to public health and regulatory oversight, which aligns with its ongoing mission.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), on his own behalf and on behalf of all SFDA staff, extended his warmest congratulations and best wishes to the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and H.R.H Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister—may Allah protect them—and to the Saudi people, on the occasion of Eid al-Fitr 1447 AH.
Dr. Aljadhey commended the services provided by the Kingdom during the holy month of Ramadan to pilgrims and visitors to the Two Holy Mosques, which contributed to the success of the Umrah season in an atmosphere of tranquility and peace. He noted that this success was achieved by the grace of God and the continuous guidance and support of the wise leadership, which dedicated all available resources to ensure the utmost care and attention for the guests of the Two Holy Mosques.
Furthermore, Dr. Aljadhey highlighted the SFDA’s vital role in ensuring the safety and quality of food, medicine, and medical devices, thereby protecting public health and the safety of pilgrims. He emphasized the Kingdom's international leadership in the fields of regulatory oversight and inspection, in alignment with the aspirations and commitment of the leadership.
His Excellency concluded by praying to Allah Almighty to grant the Custodian of the Two Holy Mosques and H.R.H the Crown Prince continued health and well-being, and to reward their tireless efforts in serving the nation, its citizens, and the visitors to the Two Holy Mosques. He also prayed that Allah preserve the Kingdom's security and prosperity, and that this blessed occasion returns to all with goodness, blessings, and joy.
2026-03-10
Drugs SFDA Grants Breakthrough Designation to "Bemlayo" for Adults with Obesity or Overweight
2026-03-03
Drugs SFDA Grants Orphan Drug Designation to "Agamree" for Duchenne Muscular Dystrophy
2026-03-02
Drugs SFDA Grants Orphan Drug Designation to "HYRNUO" for Advanced Non-Small Cell Lung Cancer
News List
Get daily alerts for Saudi SFDA News
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from SFDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Saudi SFDA News publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.